Login to Your Account



Iconic Therapeutics raises $20M to advance wet AMD program

By Michael Fitzhugh
Staff Writer

Wednesday, April 16, 2014
Iconic Therapeutics Inc., a small company developing a new therapy for wet age-related macular degeneration (AMD), raised $20 million in new equity financing and appointed MPM Capital partner William Greene CEO to lead the company through mid-stage testing and beyond.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription